Viewing Study NCT06140693



Ignite Creation Date: 2024-05-06 @ 7:48 PM
Last Modification Date: 2024-10-26 @ 3:14 PM
Study NCT ID: NCT06140693
Status: RECRUITING
Last Update Posted: 2023-11-29
First Post: 2023-11-09

Brief Title: A Comparison of Affective Responses During Continuous and Interval Exercise
Sponsor: University of Stirling
Organization: University of Stirling

Study Overview

Official Title: A Comparison of Affective Responses During Continuous and Interval Exercise
Status: RECRUITING
Status Verified Date: 2023-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Regular exercise is important for good health but many people do not achieve the minimum physical activity recommendations How exercise makes people feel is an important factor in how much exercise people do Affective valence AV is a measure of the pleasure andor displeasure people feel It has been suggested that if the drop in AV with exercise can be minimised then people will be more likely to enjoy the exercise and adhere to the exercise long-term

Much research has been done to elucidate the factors that affect changes in AV with exercise with a focus on exercise intensity It has been hypothesised that AV will increase with low to moderate exercise intensities but will decrease with higher exercise intensities This has led a number of researchers to claim that there is little value in research examining the health benefits of high-intensity interval training HIIT andor sprint interval training SIT as the exercise intensities used in these exercise routines are so high that affective valence is expected to drop to levels that are suggested to be unpalatable to members of the general public

However this hypothesis ignores the likely moderating effect of exercise duration most available evidence indicates that affect drops over time with increasing exercise duration This means that it is possible for a longer exercise bout at a lower intensity to be associated with a greater drop in AV compared to a shorter bout of exercise at a higher intensity This may explain why recent studies have demonstrated that low-volume SIT protocols may be associated with a similar drop in AV compared to moderate-intensity continuous exercise but are considered more enjoyable

It is hypothesised that exercise enjoyment and subsequent uptake and adherence to an exercise routine is linked to the amount of time spent at reduced AV rather than the absolute drop in AV per se To investigate this hypothesis changes in affective valence will be measured in response to three bouts of moderate intensity continuous exercise at different intensities but equal duration 30 minutes as well as two bouts of SIT involving different numbers of sprint repetitions and sprint duration but equal intensity It will be determined whether exercise enjoyment is related to the time spent at reduced levels of AV

The overall aim of this study is to further elucidate the exercise protocol parameters that influence changes in AV with exercise
Detailed Description: Participants

The aim is to recruit up to 30 healthy participants 15 men and 15 women from one site University of Stirling Participants will be reimbursed 50 for the time required to participate in this study The required data to perform a power analysis was not available so the number of participants will be replicated from Ekkekakis et al 2008 Exclusion criteria will be age 18 or 40 y answering yes to one or more questions of the physical activity readiness questionnaire PAR-Q a resting heart rate 100 bpm andor clinically significant hypertension 14090 mm Hg Blood pressure results will be provided to the participants with a note that they should contact their GP if they have any concerns about their blood pressure Participants will be asked to visit the lab 8 times Pregnant participants will be excluded from participation Participants will be asked to provide written informed consent prior to participation

Initial visit

At least 48 hours after having been sent an electronic copy of the participant information sheet volunteers are asked to visit our lab The study will be fully explained and volunteers will have the opportunity to ask any questions they may have before they are asked to sign an informed consent form Following this eligibility to participate will be checked by measuring height body mass resting blood pressure systolicdiastolic and heart rate as well as current physical activity level International Physical Activity Questionnaire IPAQ and potential health-related reasons why participation would not be appropriate PAR-Q general health questionnaire If the volunteer is eligible to participate then they will be asked to complete a fitness test to measure their maximal aerobic capacity VO2max and determine their ventilatory threshold VT Participants will start cycling on a stationary bike at a low intensity 50 Watts The intensity will increase by 1 W every 3 s until volitional exhaustion or an inability to maintain pedalling frequency of 60 RPM Expired O2 and CO2 will be continuously measured using a COSMED breath-by-breath gas analyser VO2 is determined as the highest value for a 15-breath rolling average of VO2 The VT is determined by the procedure described by Davis et al 1979 The procedure consists of plotting the ventilatory equivalents for oxygen VEVO2 and carbon dioxide VEVCO2 over the course of the test and identifying the point at which there is a systematic increase in VEVCO2 without a corresponding increase in VEVO2

Familiarisation Session

Participants will visit the lab once more before the experimental sessions begin In this session they will be familiarised with the continuous exercise intensities and the SIT sprints To familiarise for the continuous exercise each participant will cycle on the cycle ergometer for 5 min at each of the 3 intensities while ventilatory and heart rate responses are monitored After the initial rapid increase in oxygen update first 2-3 min the settings on the cycle ergometer will be adjusted to elicit the desired level of VO2 80 100 and 110 of VO2 at the VT Between each 5-min cycle potentially longer if multiple adjustments are required participants will be allowed to recover for as long as necessary for their heart rate to return to within 10 bpm of the pre-exercise value Following on from this again after heart rate has returned to within 10 bpm of pre-exercise participants are asked to complete two maximal sprints both of which will be performed on a mechanically braked cycle ergometer Participants will cycle against 25 W resistance for 1 min 40 s before completing a 20-s maximal sprint against a resistance of 75 of their first visit bodyweight Once this sprint is completed participants will continue cycling against 25 W resistance for a further 3 min and 30 s before completing a 30-s maximal sprint against a resistance of 75 of the participants bodyweight After the second sprint is finished participants will continue cycling against 25 W resistance for a further 4 min before the session is completed

Experimental Sessions

Sessions 3-7 will be the experimental sessions consisting of the three continuous exercise conditions and the two SIT conditions in a randomised order so as to not introduce order effects To further decrease the risk of bias the participants will not be told which of the 3 intensities of continuous exercise they are performing

For the three continuous exercise protocols the participants will be asked on arrival to complete pre-exercise self-report measures the feeling scale FS for affective valence Hardy and Rejeski 1989 and the felt-arousal scale FAS Svebak and Murgatroyd 1985 The participants will then be fitted with a heart rate monitor on their chest Participants will warm up by cycling for 5 min at 05 Wkg During the final 15 s of the warm-up participants will be asked to rate their affective valence and felt arousal When the warm-up is completed the resistance of the cycle ergometer will be increased to a level that matches the selected intensity for that session This resistance will be maintained for the following 30 min Affective valence and felt arousal will be measured during the last 15 s of minutes 3 6 9 15 18 21 24 27 and 30 Once the session is completed participants will begin a 5-min cool-down by cycling at a 05 Wkg resistance Remembered enjoyment will be recorded using the PACES questionnaire 10 min after exercise completion

For one of the SIT sessions participants will complete a 10-min cycling bout at 25 W resistance interspersed with two 20 s supramaximal sprints Affective valence and felt arousal will be measured at rest pre-exercise and then 15 s before each sprint halfway through each sprint 15 s into each sprint at the completion of each sprint and then 15 s after each sprint Affective valence and felt arousal will also be measured half-way through the low-intensity sections of the protocol at 430 min and 830 min as well as at the completion of the session Heart rate and power output will also be measured throughout the session Remembered enjoyment will be recorded using the PACES questionnaire 10 min after exercise completion

For the other SIT session participants will complete a 22-min cycling bout at 25 W resistance interspersed with four 30 s sprints including a 4 min warm-up and 4-min recovery intervals after each sprint Affective valence and felt arousal will be measured at rest pre-exercise and then 15 s before each sprint halfway through each sprint 25 s into each sprint at the completion of each sprint 430 min 9 min 1330 min 18 min and then 15 s after each sprint Affective valence and felt arousal will also be measured half-way through the low-intensity sections of the protocol 630 min 11 min 1530 min and 20 min as well as at the completion of the session Heart rate and power output will also be measured throughout the session Remembered enjoyment will be recorded using the PACES questionnaire 10 min after exercise completion

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None